Cargando…

Paracrine Factors in Uremic Cardiomyopathy

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Sucharov, Carmen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046544/ https://www.ncbi.nlm.nih.gov/pubmed/32142069 http://dx.doi.org/10.1016/j.jacbts.2020.01.005

Ejemplares similares

Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome
por: Trimarchi, Hernán, et al.
Publicado: (2020)

To Breastfeed or Not to Breastfeed With Peripartum Cardiomyopathy
por: Arany, Zoltan, et al.
Publicado: (2019)

Emerging Therapies for Dystrophic Cardiomyopathy
por: Garry, Daniel J., et al.
Publicado: (2019)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Variable Morphology of Stress-Induced Cardiomyopathy
por: Ryu, Dong Ryeol
Publicado: (2013)

Echocardiography in takotsubo cardiomyopathy; a useful approach?
por: van der Wall, E. E., et al.
Publicado: (2010)

Takotsubo cardiomyopathy – stunning views on the broken heart
por: Teske, A. J., et al.
Publicado: (2016)

Modeling Human Dilated Cardiomyopathy Using Humans
por: Gacita, Anthony M., et al.
Publicado: (2018)

Role of the Extracellular Matrix in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Marian, Ali J.
Publicado: (2019)

Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?
por: van der Wall, E. E.
Publicado: (2009)

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy
por: Maron, Martin S.
Publicado: (2019)

Detection of apical hypertrophic cardiomyopathy; which is the appropriate imaging modality
por: van der Wall, E. E., et al.
Publicado: (2008)

Right ventricular function in dilated cardiomyopathy: women are the stronger sex!
por: Merkus, D.
Publicado: (2015)

The Role of Mecahnical Dyssynchrony on Functional Mitral Regurgitation in Patients with Dilated Cardiomyopathy
por: Kim, Jang-Young
Publicado: (2011)

The phospholamban p.Arg14del founder mutation in Dutch patients with arrhythmogenic cardiomyopathy
por: van der Heijden, J. F., et al.
Publicado: (2013)

DNA Damage Prediction Tool in Dilated Cardiomyopathy: Don’t Go Breaking My Heart
por: Jimenez, Jesus, et al.
Publicado: (2019)

Three’s Company: A Rare Case of a Myocardial Bridge With Concomitant SCAD and Takotsubo Cardiomyopathy
por: Gianos, Eugenia, et al.
Publicado: (2021)

Three dimensional echocardiography: a valuable tool to assess left atrial function in non-compaction cardiomyopathy!
por: Baur, Leo H. B.
Publicado: (2007)

How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. J. Clin. Med. 2023, 12, 1412
por: Kataoka, Naoya, et al.
Publicado: (2023)

JPH2 Mutant Gene Causes Familial Hypertrophic Cardiomyopathy: A Possible Model to Unravel the Subtlety of Calcium-Regulated Contractility
por: Roberts, Robert
Publicado: (2017)

Long-term Benefits of Risk Factor Reduction in Takotsubo Cardiomyopathy.—A Comment on Khalighi et al. Entitled “Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction”, J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
por: Ponamgi, Shiva P., et al.
Publicado: (2016)

T(1) and T(2) Mapping in Uremic Cardiomyopathy: An Update
por: Arcari, Luca, et al.
Publicado: (2022)

Left ventricular strain echocardiography in advanced uremic cardiomyopathy compared to dilated cardiomyopathy
por: Mohammadi, Rizan, et al.
Publicado: (2023)

miRNAs in Uremic Cardiomyopathy: A Comprehensive Review
por: D’Agostino, Mario, et al.
Publicado: (2023)

Implications of uremic cardiomyopathy for the practicing clinician: an educational review
por: Hiraiwa, Hiroaki, et al.
Publicado: (2023)

Gut Microbiota Dynamics and Uremic Toxins
por: Mishima, Eikan, et al.
Publicado: (2022)

Percutaneous Septal Reduction Therapy in a Patient with Severely Symptomatic Hypertrophic Obstructive Cardiomyopathy: An experience from a tertiary care centre
por: Al Lawati, Hatim, et al.
Publicado: (2022)

The Redox-Sensitive Na/K-ATPase Signaling in Uremic Cardiomyopathy
por: Liu, Jiang, et al.
Publicado: (2020)

Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy
por: Hailu, Frehiwet T., et al.
Publicado: (2023)

The contribution of mutations in MYH7 to the onset of cardiomyopathy
por: Bollen, I. A. E., et al.
Publicado: (2017)

New therapies to treat inherited cardiomyopathies are on the way
por: Vlasman, P., et al.
Publicado: (2022)

Brain-derived neurotrophic factor in heart failure
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Lowered Resistance an Important Etiological Factor in Pneumonia
Publicado: (1918)

Contrast nephropathy: Risk factors and the role of beta blockers
por: Bowden, Rodney G.
Publicado: (2015)

Klotho, the elusive kidney-derived anti-ageing factor
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2019)

Is It Possible to Predict Respiratory Evolution in COVID-19 Patients?
por: Barbas, Carmen Silvia Valente, et al.
Publicado: (2022)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
por: Law, Jonathan P., et al.
Publicado: (2020)

GDF-11 as a Potential Cardiac Pro-Angiogenic Factor
por: Kato, Tomohiro, et al.
Publicado: (2023)

Risk factors for inguinal lymph node metastasis in patients with penile cancer
por: Koifman, Leandro
Publicado: (2022)

A Bibliometric and Visualized Analysis of Uremic Cardiomyopathy From 1990 to 2021
por: Bao, Jing-Fu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_san1vpfsljegeqqrvml8ij5ctm